易明医药：获得政府补助约1932万元

Group 1 - The company Yiming Pharmaceutical announced a government subsidy of approximately 19.32 million yuan, which accounts for 42.07% of the audited net profit attributable to shareholders for the fiscal year 2024 [1] - For the first half of 2025, the revenue composition of Yiming Pharmaceutical is as follows: 99.71% from drug sales, 0.58% from other sources, and -0.29% from drug promotion services [1] - As of the report date, Yiming Pharmaceutical has a market capitalization of 3.7 billion yuan [1]